These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

235 related articles for article (PubMed ID: 26449842)

  • 1. Emerging Therapeutic Targets for Male Germ Cell Tumors.
    Fankhauser CD; Honecker F; Beyer J; Bode PK
    Curr Oncol Rep; 2015 Dec; 17(12):54. PubMed ID: 26449842
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Third-line chemotherapy and novel agents for metastatic germ cell tumors.
    Veenstra CM; Vaughn DJ
    Hematol Oncol Clin North Am; 2011 Jun; 25(3):577-91, ix. PubMed ID: 21570610
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Investigational targeted therapies for the treatment of testicular germ cell tumors.
    Oing C; Kollmannsberger C; Oechsle K; Bokemeyer C
    Expert Opin Investig Drugs; 2016 Sep; 25(9):1033-43. PubMed ID: 27286362
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Targeted treatment approaches in refractory germ cell tumors.
    Galvez-Carvajal L; Sanchez-Muñoz A; Ribelles N; Saez M; Baena J; Ruiz S; Ithurbisquy C; Alba E
    Crit Rev Oncol Hematol; 2019 Nov; 143():130-138. PubMed ID: 31634730
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Epigenetic treatment combinations to effectively target cisplatin-resistant germ cell tumors: past, present, and future considerations.
    Oing C; Skowron MA; Bokemeyer C; Nettersheim D
    Andrology; 2019 Jul; 7(4):487-497. PubMed ID: 30924611
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Current Management of Refractory Germ Cell Tumors and Future Directions.
    Allen JC; Kirschner A; Scarpato KR; Morgans AK
    Curr Oncol Rep; 2017 Feb; 19(2):8. PubMed ID: 28220447
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Chemotherapy for good-risk germ cell tumors: current concepts and controversies.
    Vaughn DJ
    Urol Clin North Am; 2007 May; 34(2):171-7; abstract viii-ix. PubMed ID: 17484922
    [TBL] [Abstract][Full Text] [Related]  

  • 8. First-line chemotherapy of non-seminomatous germ cell tumors(NSGCTs).
    Pliarchopoulou K; Pectasides D
    Cancer Treat Rev; 2009 Nov; 35(7):563-9. PubMed ID: 19576697
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Therapeutical interference with the epigenetic landscape of germ cell tumors: a comparative drug study and new mechanistical insights.
    Müller MR; Burmeister A; Skowron MA; Stephan A; Bremmer F; Wakileh GA; Petzsch P; Köhrer K; Albers P; Nettersheim D
    Clin Epigenetics; 2022 Jan; 14(1):5. PubMed ID: 34996497
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Sunitinib inhibits tumor growth and synergizes with cisplatin in orthotopic models of cisplatin-sensitive and cisplatin-resistant human testicular germ cell tumors.
    Castillo-Avila W; Piulats JM; Garcia Del Muro X; Vidal A; Condom E; Casanovas O; Mora J; Germà JR; Capellà G; Villanueva A; Viñals F
    Clin Cancer Res; 2009 May; 15(10):3384-95. PubMed ID: 19417025
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prognostic analysis of Japanese men with metastatic germ cell tumors showing favorable response to bleomycin, etoposide and cisplatin as first-line chemotherapy.
    Kumano M; Miyake H; Hara I; Muramaki M; Takenaka A; Fujisawa M
    Hinyokika Kiyo; 2007 Dec; 53(12):851-6. PubMed ID: 18203521
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Molecular targets for the treatment of testicular germ cell tumors.
    Chieffi P
    Mini Rev Med Chem; 2007 Jul; 7(7):755-9. PubMed ID: 17627586
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Curing metastatic cancer: lessons from testicular germ-cell tumours.
    Masters JR; Köberle B
    Nat Rev Cancer; 2003 Jul; 3(7):517-25. PubMed ID: 12835671
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Intermediate and long-term complications associated with adjuvant chemotherapy for stage I germ cell tumor patients.
    Suarez-Ibarrola R; Abufaraj M; Shariat SF
    Curr Opin Urol; 2018 Sep; 28(5):485-490. PubMed ID: 30044319
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Ischemic stroke during cisplatin-based chemotherapy for testicular germ cell tumor: case report and review of the literature.
    Meattini I; Scotti V; Pescini F; Livi L; Sulprizio S; Palumbo V; Sarti C; Biti G
    J Chemother; 2010 Apr; 22(2):134-6. PubMed ID: 20435575
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Current chemotherapeutic approaches for recurrent or refractory germ cell tumors.
    O'Carrigan B; Grimison P
    Urol Oncol; 2015 Aug; 33(8):343-54. PubMed ID: 25308563
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Targeted therapies in the treatment of germ cell tumors: the need for new approaches against "orphan" tumors.
    Sánchez-Muñoz A; Jiménez-Rodríguez B; Navarro-Pérez V; Medina-Rodríguez L; Llácer C; Vicioso L; Machuca J; Alba E
    Crit Rev Oncol Hematol; 2012 Sep; 83(3):444-51. PubMed ID: 22230258
    [TBL] [Abstract][Full Text] [Related]  

  • 18. High-dose chemotherapy for male germ cell tumor.
    Hara I; Miyake H; Yamada Y; Takenaka A; Fujisawa M
    Int J Urol; 2006 Aug; 13(8):1037-44. PubMed ID: 16903926
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Etoposide and cisplatin chemotherapy for metastatic good-risk germ cell tumors.
    Kondagunta GV; Bacik J; Bajorin D; Dobrzynski D; Sheinfeld J; Motzer RJ; Bosl GJ
    J Clin Oncol; 2005 Dec; 23(36):9290-4. PubMed ID: 16361627
    [TBL] [Abstract][Full Text] [Related]  

  • 20. EGF Receptor and mTORC1 Are Novel Therapeutic Targets in Nonseminomatous Germ Cell Tumors.
    Chen KS; Fustino NJ; Shukla AA; Stroup EK; Budhipramono A; Ateek C; Stuart SH; Yamaguchi K; Kapur P; Frazier AL; Lum L; Looijenga LHJ; Laetsch TW; Rakheja D; Amatruda JF
    Mol Cancer Ther; 2018 May; 17(5):1079-1089. PubMed ID: 29483210
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.